Afatinib Completed Phase 1 Trials for Healthy Volunteers / Liver Diseases Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01298063Influence of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Various Doses of Afatinib
NCT01426958Investigation of Ritonavir Effects on Afatinib Exposure in Healthy Subjects
NCT02171754Relative Bioavailability of a Single-dose Administration of BIBW 2992 and Multiple-dose Administration of Ritonavir in Healthy Volunteers
NCT01396265Drug Interaction Study With Rifampicin and Afatinib